Toll-like receptor 9 (TLR9) is expressed intracellularly by dendritic cells (DCs) and specifically recognizes unmethylated CpG motif. Recognition of TLR9 to CpG DNA can induce DC maturation followed by the subsequent immune responses. Here, RNA interference (RNAi) was used to identify the effect of CpG DNA signaling on DC function. The results showed that transfection of DCs with siRNA specific for TLR9 gene significantly down-regulated TLR9 expression. Immature DCs transfected with TLR9 siRNA did not differentiate into mature DCs with exposure to CpG. TLR9 siRNA-treated DCs expressed low levels of MHC II and CD40 without reducing endocytosis. Furthermore, TLR9 siRNA-transfected DCs exhibited a decreased allostimulatory capacity in a lymphocyte proliferation assay and attenuated Th1 responses by decreasing IL-12p70 production. Our findings indicate that siRNA in silencing TLR9 gene in DCs may offer a potential tool to study the TLR9-CpG pathway.
Introduction
Unmethylated CpG DNA in bacterial DNA has been known as one of the key immunostimulatory pathogen specific molecular patterns (PAMPs). CpG DNA can induce immune cell to up-regulate certain surface molecules and stimulate antigen-presenting cells (APC) to secrete cytokines (1) (2) (3) . Synthetic oligodeoxynucleotides containing the unmethylated CpG motif (CpG ODN) are equivalent to bacterial DNA in the immunostimulatory activity. TLR9, which is expressed intracellularly by certain immune cells, has been considered as the most important receptor for CpG. Analysis of TLR9-deficient mice revealed that TLR9 is not only essential for pro-inflammatory cytokine production and other inflammatory responses, but also plays a role in the induction of T helper 1 (Th1) acquired immune response (4) .
DC is one of the most important cell populations for both innate and acquired immunity. Hitherto, the roles of the CpG-TLR9 pathway in DC biological activity were studied by mainly utilizing the DCs from TLR9-deficient mice or MyD88-deficient mice (MyD88 is known to be an essential adaptor for initiating TLR9 signaling) (5). Cerullo V et al. demonstrated that TLR9 deficiency attenuated the innate immune response, whereas TLR9 blockade reduced the acute inflammatory response (6) . RNAi is the technique of post-transcriptional dsRNA-dependent gene silencing and has been recently shown to be a most powerful approach for analyzing gene functions (7) . It has never been reported whether RNAi could be used as a new tool for studying the CpG-TLR9 pathway in DC biological activity. In the present study, TLR9 siRNA was chemically synthesized and transferred into DCs by Lipofectamine 2000. It was found that TLR9 expression in TLR9 siRNA-treated DCs was significantly inhibited. Silencing the TLR9 gene in DCs had no effect on their viability. TLR9 siRNA-treated DCs expressed low levels of MHC II and CD40 and produced less IL-12p70 without reducing endocytosis. Furthermore, TLR9 siRNA-treated DCs obviously decreased lymphocyte proliferation when DCs were co-cultured with allogeneic lymphocytes. Taken together, TLR9-silenced DCs by RNAi will be a useful model for clarifying to what extent recognition of CpG DNA contributes to host immune responses against bacterial infection.
Materials and Methods

Animals
Specific pathogen-free 4-6 weeks old C57BL/6 mice were purchased from the Animal Research Center of Yangzhou University. The animals were maintained on standard rodent chow and water. All mice were given at least 1 week to acclimate to their surroundings prior to use. The experiments were conducted according to institutional animal ethics guidelines.
Reagents
RPMI 1640 was bought from GiBCO (USA). Fetal calf serum (FCS) was purchased from HyClone Laboratories (Inc., Logan, UT, USA). Recombinant GM-CSF was from Biocourse (USA) and recombinant IL-4 was from Peprotech (USA). Anti-mouse APC-CD40 and APC-MHC II were bought from eBioscience (Inc, USA). FITC-dextran was bought from Sigma. Cell counting kit 8 was bought from Dojindo Laboratories (Inc, Japan). Mouse IL-12p70 ELISA kit was bought from Bender (USA). CpG 1668 with the sequence of 5'-TCC ATG ACG TTC CTG ATG CT-3' was synthesized from Invitrogen (Shanghai, China).
Generation of bone marrow-derived DCs
DCs were generated from bone marrow progenitor cells as previously described with some modifications (8) . Briefly, bone marrow cells were isolated from tibiae and femurs of mice and treated with red blood cells lysing buffer (150 mM NH 4 Cl, 10 mM NaHCO 3 and 0.4% EDTA). Cell density was adjusted to 1 × 10 6 cells with complete medium (RPMI 1640 supplemented with 10% FCS, 100 U/ml penicillin, 100 g/ml streptomycin, 10 ng/ml recombinant GM-CSF and 1 ng/ml recombinant IL-4) and seeded into 12-well plates at 2 ml/well. All cultures were incubated at 37°C in 5% humidified CO 2 . Non-adherent granulocytes were removed after 48 h of culture and then fresh complete medium was added. Media were exchanged by half every 48 h. After 6 days of culture, non-adherent and loosely adherent cells were harvested and > 85% of the cells expressed characteristic DC-specific markers as determined by FACS. The mouse bone marrow-derived DCs were transferred into new 12-well plates for siRNA transfection.
siRNA design, synthesis and transfection
The siRNA sequences used for silencing of murine TLR9 [Genbank access number: NM_031178] were designed by Block-iT TM RNAi Designer online software (Invitrogen). Sequences were synthesized and annealed by the manufacturer (Invitrogen, Shanghai, China) ( Table 1 ). The negative control siRNA (scrambled siRNA) was provided by Invitrogen. siRNA was facilitated by Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. The final siRNA concentration was 100 nM. Silencing effect of RNAi on DCs was detected after the treated DCs were incubated at 37°C in 5% humidified CO 2 for 48 h. Subsequently, DCs were stimulated with CpG for 24 h for following experiments.
RNA extraction and RT-PCR
Total RNAs were extracted by using the Trizol Reagent (Invitrogen, USA) according to the manufacturer's instructions. RNA concentrations were quantified by spectrophotometer at 260 nm. Total RNA (1 g) was reverse- transcribed using Revert AidTM First Strand cDNA Synthesis kit (Fermentas). Subsequently, 2 l of the incubation mixture was used as the template for the following PCR using 2× Taq Enzyme Mix kit (TianGen, China). Oligonucleotides as primers were synthesized by Invitrogen (shanghai, China) and listed in Table 2 . PCR was carried out for 33 cycles of denaturation (45 s at 94°C), annealing (45 s at 48°C), and extension (90 s at 72°C). The PCR products were then detected on 1% agarose gel containing 0.5 g/ml ethidium bromide. The gel was put on an UV-transilluminator and photographed. TLR9 signal was measured by a densitometer and standardized against the GAPDH signal using a digital imaging and analysis system (SmartSpec TM Plus, BIO-RAD). 1
Western blot analysis
Cells (1 × 10 7 ) were lysed in a buffer containing 50 mM Tris-Cl pH 8.0, 150 mM NaCl, 0.02% NaN 3 , 0.1% SDS, 100 g/ml phenylmethylsufonyl fluoride (PMSF), 1 g/ml Aprotinin, 1% Triton. After centrifugation, cell lysates (150 g/lane) were subjected to 10% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore). The membranes were blocked for 1 h in PBST (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween-20) containing 2% nonfat dried milk, and then antibodies against TLR9 (Millpore, 1:500), -actin (Sigma, 1:400) and HRPconjugated goat anti-rabbit and anti-mouse secondary antibodies (Promab, 1:1,000) were used. Protein bands were detected by the enhanced chemiluminescence (ECL) reaction (Kibbutz Beit Haemek, Israel).
Flow cytometry
DCs were washed twice in FACS medium phosphate buffered PBS containing 1% FCS and 0.1% NaN 3 . Then the cells were incubated for 30 min at 4°C with APC-labeled CD40 and MHC II antibody according to the standard procedure. An isotype control (IgG2a) was used for each antibody. Fluorescence was measured by using a FACScan flow cytometry (Becton Dickinson) and data were analyzed by using the CellQuest Software (Becton Dickinson, San Diego, CA).
Measurement of endocytosis
Endocytosis of DCs was measured by the cellular uptake of FITC-labeled dextran and quantified by flow cytometry. Briefly, DCs were incubated with FITC-dextran (final concentration: 0.2 mg/ml) at 37°C for 1 h. Thereafter, DCs were collected and washed twice with cold flow buffer in flow tube, and finally cells were resuspended with 1.2 mg/ml trypan blue. Trypan blue was used to quench surface-bound fluorescence and filtered with 0.45 m filter paper before use (9).
Enzyme-linked immunosorbent assay (ELISA)
ELISA kit of IL-12p70 was conducted according to the manufacture's protocol. Briefly, every group of cell culture supernatant and IL-12p70 standards were added to the 96-well plates coated with mouse monoclonal antibody in duplicate, and biotinylated detection antibodies were added immediately and incubated for 2 h at room temperature. Afterwards, the wells were washed three times, HRPconjugated solution was added to each well, and incubated for 1 h at 18-25°C. Following washed three times, TMB substrate solution was added to each well and incubated for 15 min at 24°C in the dark and then the stop solution was added to each well. At last, the absorbance was determined at 450 nm by using a microplate reader (Bio-Tek).
Allogeneic mixed lymphocyte reaction (MLR in vitro)
Functional activity of DCs was reflected in the primary allogeneic MLR assay. T cells as responder cells were obtained from an allogeneic mouse spleen use nylon wool. MLR assays were carried out in 96-well round-bottom plates (200 l/well) to ensure efficient DC/T cell contact. T cells were implanted with DC at 3 × 10 5 /well (DC: T cell = 1:5, 1:10, 1:30, and 1:100) for 3 days in CO 2 incubator. Then cell proliferation was assayed by using a Cell counting kit-8 (Dojindo) according to the manufacturer's instructions. Each group was designed three parallel wells.
Statistical analysis
Results were expressed as mean ± SD. Statistical significance was assessed by one way analysis of variance (ANOVA) and the ANOVA post Bonferronites by the software of Graphpad Prism 5.0. Differences between groups were considered significant when p < 0.05. 
Results
Detection of TLR9 expression of DCs transfected with siRNA
To observe the interference effect of siRNA, DCs were transfected with three different siRNA, respectively. DCs transfected with scrambled siRNA and without any treatment were used as negative controls. After transfection, TLR9 expression levels were examined by RT-PCR and Western blot. As shown in Figure 1 , TLR9 expression both at gene ( Figure 1A ) and protein levels ( Figure 1B) 
TLR9 siRNA-transfected DCs remain high endocytosis capability after CpG stimulation
CpG-stimulated DCs demonstrated reduced endocytosis to suggest their functional maturation. As shown in Figure 3 , CpG stimulants significantly decreased DC endocytosis compared to unstimulated control. However, TLR9 siRNAtransfected group remains relatively high endocytosis compared with untransfected and scrambled siRNAtransfected groups.
Low IL-12p70 expression by CpG-stimulated DCs pretreated with TLR9 specific siRNA DCs transfected with siRNA9.1 and siRNA9.2 were stimulated by CpG (1 M). The cell supernatants were harvested and cytokines levels were determined 24 h-post stimulation. As shown in Figure 4 , the expression levels of IL-12p70 in the interference groups were significantly decreased when compared with untransfected group and scrambled siRNA-transfected group.
TLR9 low DCs stimulate low proliferative responses in allogeneic T cells
To examine the effect of TLR9 siRNA on DC allostimulatory activity, DCs transfected with or without TLR9 siRNA were cocultured with C57BL/6 splenic T cells at various ratios in a 3-day MLR. As shown in Figure 5 , in untransfected group, CpG-stimulated DCs obviously promoted the proliferation of allogeneic T cells, whereas DCs transfected with siRNA9.1 and siRNA9.2 induced significantly less allogeneic T cell proliferation (p < 0.05) after CpG stimulation. DCs transfected with scrambled siRNA retained high allostimulatory activity (p > 0.05 compared with Untreatment group), indicating the specificity of TLR9 siRNA.
Discussion
A vast array of data indicated that TLR9 plays a key role in DNA-induced innate immunity and links it with a role in acquired immunity through the activation of various cell types, such as DCs and B cells (10) . Its intracellular signaling pathway has been elucidated at the molecular level. Upon CpG binding, TLR9 associates with the adaptor molecule MyD88 to initiate CpG-dependent effects via signal transducing proteins such as members of the IL-1 receptor-associated kinase (IRAK) family, mitogen activated kinases (MAPK), or IFN regulatory factors (11) (12) (13) . These events lead to the activation of nuclear factor κB (NF-κB) transcription factors, cytokine production, or expression of co-stimulatory molecules in immune cells (14) . Hemmi et al. showed that TLR9-deficient (TLR9 -/-) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory cytokine production from macrophages and maturation of DCs (4). TLR9
-/-mice showed resistance to the lethal effect of CpG DNA without any elevation of serum pro-inflammatory cytokine levels. The in vivo CpG-DNAmediated T-helper type-1 response was also abolished in Allogeneic lymphocytes isolated from spleens were incubated with these cells at the indicated ratio of DC/lymphocyte for 3 days. Proliferation was determined by using the CCK8 assay kit. Data were shown as mean ± SD from three independent experiments, *p < 0.05.
TLR9
-/-mice. These works demonstrated that TLR9 was essential for CpG DNA-induced immune responses.
DCs are professional APCs with key regulatory roles in the activation of innate and adaptive immunity. Immature DCs readily take up CpG and then become a mature state and up-regulate the presentation of those cell surface proteins involved in T cell activation, including MHC II and co-stimulatory molecules (15) . Our data presented here, together with previous findings, indicated that murine bone marrow DC of C57BL/6 mice could be effectively induced to mature state by CpG 1668.
Although gene knockout has been used to inhibit TLR9 expression, RNAi appears to be more attractive due to several distinct advantages with extremely efficient (16) and specific characters (17) . Moreover, this technique is not difficult to perform and its effect can be confirmed within days using simple detection systems, such as RT-PCR, ELISA, and Western blot (18) . To date, RNAi technology has generated much insight into the development, activation and function of cells comprising the innate and adaptive immune systems (19) . In addition, RNAi has contributed significantly to the understanding of immune responses to pathogenesis. As depicted in our study, TLR9 expression in TLR9 siRNA-treated DCs was significantly inhibited at both gene and protein levels, which were estimated by the RT-PCR and western blot technique, respectively (Figure 1 ). Our studies revealed that no variations in the viability of TLR9 siRNA-transfected DCs and the parallel control DCs were detected (data not shown). This showed that siRNA did not affect the viability of DCs.
Since DCs in an immature state with the capacity to efficiently capture and/or internalize microbial pathogens, we found that untransfected-DCs had high endocytosis capability. Once treated with CpG, untransfected-DCs as well as scrambled siRNA-transfected DCs could not effectively uptake FITC-dextran, while TLR9 siRNA-transfected DCs remained relatively high endocytosis capability. This indicated that it was hard to induce DC maturation by CpG when treated with TLR9 siRNA. CpG-containing bacterial DNA is a potent stimulant for DCs to support T-helper type-1 (Th1) cell development. Therefore, we examined CpG-DNAinduced up-regulation of surface molecules and cytokine production in murine bone-marrow-derived DCs. Untransfected DCs and scrambled siRNA-transfected DCs showed enhanced surface expression of CD40 and MHC II when stimulated with CpG. TLR9 siRNA-treated DCs did not show any enhanced expression of the surface molecules in response to CpG. Untransfected DCs and scrambled siRNAtransfected DCs produced IL-12p70 in response to CpG, while TLR9 siRNA-treated DCs produce much less detectable level of IL-12p70. Furthermore, TLR9 siRNAtreated DCs obviousely decreased lymphocyte proliferation when DCs were co-cultured with allogeneic lymphocytes.
In summary, our results indicated that silencing TLR9 gene by RNAi did not affect the viability of DCs derived from C57BL/6 mice. Furthermore, TLR9 siRNA-transfected DCs could not been induced into mature state by CpG. siRNA in silencing TLR9 gene in DCs may offer a potential approach in modulating the immune system to bolster immune responses, control inflammation, or treat autoimmune disorders.
